ctrl K

Price Alert

Keros Therapeutics Inc. (KROS)

NASDAQ: KROS · Real-Time Price · USD

14.46

0.04 (0.28%)

At close: Aug 15, 2025, 3:59 PM

14.08

-2.66%

After-hours: Aug 15, 2025, 05:42 PM EDT

Keros Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	559.93M	331.15M	279.05M	230.04M
Short-Term Investments	n/a	n/a	n/a	n/a
Long-Term Investments	1.45M	1.21M	1.33M	1.33M
Other Long-Term Assets	2.06M	2.05M	2.12M	82K
Receivables	4.46M	1.09M	841K	18M
Inventory	n/a	n/a	-841K	3.06M
Other Current Assets	1.48M	1M	180K	340K
Total Current Assets	588.89M	347.29M	285.77M	251.44M
Property-Plant & Equipment	23.49M	19.47M	17.57M	2.4M
Goodwill & Intangibles	n/a	n/a	n/a	n/a
Total Long-Term Assets	26.99M	22.73M	21.01M	3.81M
Total Assets	615.89M	370.02M	306.78M	255.25M
Account Payables	4.6M	5.45M	3.34M	3.65M
Deferred Revenue	n/a	n/a	n/a	7.13M
Short-Term Debt	n/a	n/a	455K	862K
Other Current Liabilities	10.55M	10.38M	7.49M	3.99M
Total Current Liabilities	27.45M	24.37M	16.55M	11.85M
Long-Term Debt	n/a	n/a	12.81M	231K
Other Long-Term Liabilities	n/a	n/a	-12.81M	-231K
Total Long-Term Liabilities	16.88M	13.44M	12.81M	231K
Total Liabilities	44.33M	37.81M	29.36M	12.08M
Total Debt	18.86M	14.44M	13.27M	1.09M
Common Stock	4K	3K	2K	2K
Retained Earnings	-568.78M	-381.43M	-228.43M	-123.75M
Comprehensive Income	n/a	0.00	-0.00	-0.00
Shareholders Equity	571.55M	332.21M	277.42M	243.17M
Total Investments	1.45M	1.21M	1.33M	1.33M